Case report: lung adenosquamous carcinoma after multiline therapy
7 evidence topics · 1 source
Objective
Location and study date
Initial imaging date
Study design
Eligibility criteria
Not applicable.
Treatment
Ivonescimab regimen
Study outcomes
Rationale for using radiographic partial response as the reported outcome
Not applicable.
Statistical analysis description
Number of participants (Planned and analyzed)
Not applicable.
Description of analysis sets
Not applicable.
Results
Participant disposition
Baseline characteristics
Baseline age, EGFR alterations, and PD-L1 expression
Efficacy results
Radiographic response
Case report: lung adenosquamous carcinoma after multiline therapy
Health-related quality of life and patient-reported outcomes
No evidence found.
Safety results
Study limitations
Summary
The report describes one participant with adenosquamous histology and multiple previous therapies. A response sustained over six cycles cannot establish an OS benefit, comparative efficacy, or the frequency of uncommon toxicity. The findings should not be generalized to all EGFR-mutated NSCLC.